Our mission is to ensure the generation of accurate and precise findings.
Contact Info Dubai Science Park Complex, Dubai Toll Free 800 GENOMICS (800 43 666 427) [email protected]Please enter subscribe form shortcode
Please enter instagram feed shortcode
Over the past few decades, we have witnessed a revolution in sequencing technologies that have had a profound impact on our understanding of cancer & its genetic makeup. It involves the identification and analysis of specific genetic mutations that may increase a person’s risk of developing cancer or may influence the behavior of cancer cells. Genetic testing can help identify individuals who are at increased risk for certain types of cancer, allowing for earlier screening, early detection and more personalized treatment approaches.
Oncology products/tests performed at Agiomix, coupled with the use of cutting-edge sequencing technologies, can help provide all the necessary tools to treat, manage, and/or cure life-threatening cancers and their syndromes.
Prevention is better than detection! Hereditary Cancer Screening Can Save Lives.
OncoSeq® Cancer Screening Genetic Reports are based on state-of-the art analysis of your DNA at highly accredited laboratories to give you an easy-to-understand report.
The reports are designed, compiled and reviewed by a team of medical genetic professionals who examine each case carefully and ensure the quality and simplicity of the results. The reports are also supplemented with optional genetic and medical counseling for high-risk individuals
Agiomix proudly offers OncoSeq in the MENA region.
For more information, please visit www.oncoseqgx.com
Testing Process
Actionable results mean hope!
CanActgx is a comprehensive range of tumor profiling tests and reports that can give physicians and patients the power to
Agiomix proudly offers CanActgx in the MENA region.
For more information, please visit www.canactgx.com
Testing Process
Optimize & Individualize Breast Cancer Treatment!
Agiomix has partnered with Endopredict® to be able to provide the most accurate second-generation Breast Cancer prognostic test in the MENA region. The test is proven to predict each patient’s risk of early and long-term breast cancer recurrence that can help avoid over and under-treatment of breast cancer.
Agiomix proudly offers Endopredict in the MENA region.
For more information and to request the test, please contact us at [email protected]
Testing Process
